C9 and amyotrophic lateral sclerosis: Therefore, determining the structural preferences and structural ensembles under more physiologically relevant conditions is crucial to understand if targeting nucleic acid structures formed by C9-NRE DNA can be an efficacious treatment strategy for C9-NRE-linked ALS/FTD.